TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -3 | -3 | -8 | 6 | 11 | -3 | 0 |
| P | %wins | 0 | 0 | 0 | 100 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/11/17 16:01 | 1/9/17 | CNAT | Conatus Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cashion Charles | CA | O | SVP,Fina | M.d | 42 | 0.9900 | 26 | 42 | 29 | 187 | D | -17 | 163 | 132 | 158 | 176 | 161 | -6 | 0 | 2 | -3 | 2 | 39 | ||
8/31/09 14:38 | 8/31/09 | NBY | Novabay Pharmaceuticals, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Cashion Charles | CA | D | P | 2 | 1.90 | 0 | 1 | 4 | 28 | B | -3 | -3 | -8 | 6 | 11 | -3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |